Andrew Radin

Andrew co-founded twoXAR, an artificial intelligence-driven drug discovery company. From 2014-2019 he led activities in fundraising, communications, business development, and recruiting. These activities resulted in venture funding from Andreessen Horowitz, SoftBank Ventures, and OS Fund; six risk/reward-sharing drug development collaborations; and a portfolio of 15+ active drug candidate programs.

Andrew formerly worked in Macquarie Bank’s Fund of Private Equity Fund’s group helping to manage its $200 million Clean Technology Fund. While doing that he was the Race Director for the UCSD Tritonman Triathlon which they transformed into Southern California’s first certified sustainable race. Andrew has been active in leading alumni groups and helped create and grow UCSD Alumni organizations including the UCSD Biotechnology Professionals Network, UCSD Financial Professionals Network & the UCSD Alumni UK Chapter.

Andrew has biochemistry and economics degrees from UC San Diego and earned his MBA from MIT Sloan.

As Head of Strategic Corporate Development at Adnoviv, Andrew is leading investment and partnership efforts.